Online Database of Chemicals from Around the World
Search |  Submit |  中文
Home >> Chemical Listing >> C >> (11S)-11-Carboxy-2-[(1,1-dimethylethoxy)carbonyl]-5-oxo-3-oxa-2,6,12-triazatridecanedioic acid 1-(1,1-dimethylethyl) 13-(9H-fluoren-9-ylmethyl) ester

(11S)-11-Carboxy-2-[(1,1-dimethylethoxy)carbonyl]-5-oxo-3-oxa-2,6,12-triazatridecanedioic acid 1-(1,1-dimethylethyl) 13-(9H-fluoren-9-ylmethyl) ester
[CAS# 1008512-23-9]

List of Suppliers
Creative Peptides USA Inquire  
+1 (631) 624-4882
info@creative-peptides.com
Chemical manufacturer
chemBlink standard supplier since 2010
Complete supplier list of (11S)-11-Carboxy-2-[(1,1-dimethylethoxy)carbonyl]-5-oxo-3-oxa-2,6,12-triazatridecanedioic acid 1-(1,1-dimethylethyl) 13-(9H-fluoren-9-ylmethyl) ester
Identification
Name (11S)-11-Carboxy-2-[(1,1-dimethylethoxy)carbonyl]-5-oxo-3-oxa-2,6,12-triazatridecanedioic acid 1-(1,1-dimethylethyl) 13-(9H-fluoren-9-ylmethyl) ester
Molecular Structure CAS # 1008512-23-9, (11S)-11-Carboxy-2-[(1,1-dimethylethoxy)carbonyl]-5-oxo-3-oxa-2,6,12-triazatridecanedioic acid 1-(1,1-dimethylethyl) 13-(9H-fluoren-9-ylmethyl) ester
Molecular Formula C33H43N3O10
Molecular Weight 641.71
CAS Registry Number 1008512-23-9
Properties
Solubility Insoluble (5.4E-4 g/L) (25 ºC), Calc.*
Density 1.241±0.06 g/cm3 (20 ºC 760 Torr), Calc.*
* Calculated using Advanced Chemistry Development (ACD/Labs) Software V11.02 (©1994-2016 ACD/Labs)
Market Analysis Reports
List of Reports Available for (11S)-11-Carboxy-2-[(1,1-dimethylethoxy)carbonyl]-5-oxo-3-oxa-2,6,12-triazatridecanedioic acid 1-(1,1-dimethylethyl) 13-(9H-fluoren-9-ylmethyl) ester
Related Products
4-Carboxy-2,6-difluorobenzaldehyde  (Carboxydifluoromethyl)triphenylphosphonium inner salt  3(or 6)-Carboxy-9,10-dihydro-9,10-dioxo-1-anthracenyl beta-D-glucopyranosiduronic acid  (alphaS,2S,3R)-5-Carboxy-4-[[1-(4,5-dihydro-2-thiazolyl)-3-azetidinyl]thio]-2,3-dihydro-alpha-[(1R)-1-hydroxyethyl]-3-methyl-1H-pyrrole-2-acetic acid  5(or 6)-Carboxy-3',6'-dihydroxy-3-oxo-spiro[isobenzofuran-1(3H),9''-[9H]xanthene]-2',7'-dipropanoic acid  [4R-[3[1[2S*[2S*,3R*,4(3S*,5S*)],3R*],3S*,5S*],4alpha,5beta,6beta(R*)]]-3-[[1-[2-[5-Carboxy-4-[[5-[(dimethylamino)carbonyl]-3-pyrrolidinyl]thio]-2,3-dihydro-3-methyl-1H-pyrrol-2-yl]-3-hydroxy-1-oxobutyl]-5-[(dimethylamino)carbonyl]-3-pyrrolidinyl]thio]-6-(1-hydroxyethyl)-4-methyl-7-oxo-1-azabicyclo[3.2.0]hept-2-ene-2-carboxylic acid  (3S)-3-Carboxy-7-[[(1,1-dimethylethoxy)carbonyl]amino]-11,11-dimethyl-9-oxo-10-oxa-2,6,8-triazadodec-6-enoic acid 1-(9H-fluoren-9-ylmethyl) ester  (3R)-3-Carboxy-7-[[(1,1-dimethylethoxy)carbonyl]amino]-11,11-dimethyl-9-oxo-10-oxa-2,6,8-triazadodec-6-enoic acid 1-(9H-fluoren-9-ylmethyl) ester  (3R)-3-Carboxy-9-[[(1,1-dimethylethoxy)carbonyl]amino]-13,13-dimethyl-11-oxo-12-oxa-2,8,10-triazatetradec-9-enoic acid 1-(9H-fluoren-9-ylmethyl) ester  (3S)-3-Carboxy-6-[[(1,1-dimethylethoxy)carbonyl]amino]-10,10-dimethyl-8-oxo-9-oxa-2,5,7-triazaundec-5-enoic acid 1-(9H-fluoren-9-ylmethyl) ester  (3S,7S)-7-Carboxy-3-[(1,1-dimethylethoxy)methyl]-11,11-dimethyl-4,9-dioxo-5,10-dioxa-2,8-diazadodecanoic acid 1-(9H-fluoren-9-ylmethyl) ester  3-[(2S)-3-[(5S)-5-Carboxy-2,2-dimethyl-3-oxazolidinyl]-2-[[(9H-fluoren-9-ylmethoxy)carbonyl]amino]-3-oxopropyl]-1H-indole-1-carboxylic acid 1-(1,1-dimethylethyl) ester  (E)-3-Carboxy-1,1-dimethyl-2-propenyl  17-((S)-1-Carboxy-3-{2-[2-({2-[2-(2,5-dioxo-pyrrolidin-1-yloxycarbonylmethoxy)ethoxy]ethylcarbamoyl}methoxy)ethoxy]ethylcarbamoyl}propylcarbamoyl)-heptadecanoic acid  9-Carboxy Doxorubicin Impurity  3-[(1E)-2-Carboxyethenyl]-4,6-dichloro-1H-indole-2-carboxylic acid ethyl ester  5-(2-Carboxyethenyl)-2-methoxyphenyl beta-D-glucopyranosiduronic acid  4-Carboxy-3-ethoxybenzeneacetic acid  1-[2-(2-Carboxyethoxy)ethyl]-1(or 3)-(2-carboxyethyl)-4,5-dihydro-2-undecyl-1H-imidazolium hydroxide disodium salt  4-[2-[[(6R,7R)-2-Carboxy-7-[[(2Z)-(ethoxyimino)[5-(phosphonoamino)-1,2,4-thiadiazol-3-yl]acetyl]amino]-8-oxo-5-thia-1-azabicyclo[4.2.0]oct-2-en-3-yl]thio]-4-thiazolyl]-1-methylpyridinium acetate hydrate